Sonoma Pharmaceuticals Inc (SNOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 4,349 | 5,604 | 4,015 | 3,754 | 3,564 |
| Cost of Goods | 2,699 | 3,484 | 2,551 | 2,226 | 2,294 |
| Gross Profit | 1,650 | 2,120 | 1,464 | 1,528 | 1,270 |
| Operating Expenses | 3,027 | 2,941 | 3,110 | 2,410 | 2,595 |
| Operating Income | -678 | -337 | -1,095 | -656 | -1,031 |
| Other Income | -271 | -394 | -147 | 128 | 112 |
| Pre-tax Income | -949 | -731 | -1,242 | -528 | -919 |
| Income Tax | -130 | -197 | -1 | 248 | 9 |
| Net Income Continuous | -819 | -534 | -1,241 | -776 | -928 |
| Net Income | $-819 | $-534 | $-1,241 | $-776 | $-928 |
| EPS Basic Total Ops | -0.48 | -0.32 | -0.76 | -0.23 | -0.63 |
| EPS Basic Continuous Ops | -0.48 | -0.32 | -0.76 | -0.22 | -0.63 |
| EPS Diluted Total Ops | -0.48 | -0.32 | -0.76 | -0.23 | -0.63 |
| EPS Diluted Continuous Ops | -0.48 | -0.32 | -0.76 | -0.22 | -0.63 |
| EPS Diluted Before Non-Recurring Items | -0.35 | -0.13 | -0.37 | -0.15 | -0.59 |
| EBITDA(a) | $-644 | $-301 | $-1,059 | $-625 | $-998 |